426 related articles for article (PubMed ID: 37500993)
1. Nutritional and metabolic factors in amyotrophic lateral sclerosis.
Ludolph A; Dupuis L; Kasarskis E; Steyn F; Ngo S; McDermott C
Nat Rev Neurol; 2023 Sep; 19(9):511-524. PubMed ID: 37500993
[TBL] [Abstract][Full Text] [Related]
2. Altered Metabolic Homeostasis in Amyotrophic Lateral Sclerosis: Mechanisms of Energy Imbalance and Contribution to Disease Progression.
Ioannides ZA; Ngo ST; Henderson RD; McCombe PA; Steyn FJ
Neurodegener Dis; 2016; 16(5-6):382-97. PubMed ID: 27400276
[TBL] [Abstract][Full Text] [Related]
3. Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models.
Maksimovic K; Youssef M; You J; Sung HK; Park J
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238732
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Abnormalities, Dietary Risk Factors and Nutritional Management in Amyotrophic Lateral Sclerosis.
D'Amico E; Grosso G; Nieves JW; Zanghì A; Factor-Litvak P; Mitsumoto H
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34209133
[TBL] [Abstract][Full Text] [Related]
5. Nutritional state, energy intakes and energy expenditure of amyotrophic lateral sclerosis (ALS) patients.
Genton L; Viatte V; Janssens JP; Héritier AC; Pichard C
Clin Nutr; 2011 Oct; 30(5):553-9. PubMed ID: 21798636
[TBL] [Abstract][Full Text] [Related]
6. Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis.
Nelson AT; Trotti D
Neurotherapeutics; 2022 Jul; 19(4):1102-1118. PubMed ID: 35773551
[TBL] [Abstract][Full Text] [Related]
7. Hypermetabolism in ALS is associated with greater functional decline and shorter survival.
Steyn FJ; Ioannides ZA; van Eijk RPA; Heggie S; Thorpe KA; Ceslis A; Heshmat S; Henders AK; Wray NR; van den Berg LH; Henderson RD; McCombe PA; Ngo ST
J Neurol Neurosurg Psychiatry; 2018 Oct; 89(10):1016-1023. PubMed ID: 29706605
[TBL] [Abstract][Full Text] [Related]
8. AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis.
Perera ND; Turner BJ
Neurochem Res; 2016 Mar; 41(3):544-53. PubMed ID: 26202426
[TBL] [Abstract][Full Text] [Related]
9. Energy metabolism in ALS: an underappreciated opportunity?
Vandoorne T; De Bock K; Van Den Bosch L
Acta Neuropathol; 2018 Apr; 135(4):489-509. PubMed ID: 29549424
[TBL] [Abstract][Full Text] [Related]
10. Hypermetabolism associated with worse prognosis of amyotrophic lateral sclerosis.
He J; Fu J; Zhao W; Ren C; Liu P; Chen L; Li D; Tang L; Zhou L; Zhang Y; Ma X; Zhang G; Li N; Fan D
J Neurol; 2022 Mar; 269(3):1447-1455. PubMed ID: 34274994
[TBL] [Abstract][Full Text] [Related]
11. Skeletal Muscle Metabolism: Origin or Prognostic Factor for Amyotrophic Lateral Sclerosis (ALS) Development?
Quessada C; Bouscary A; René F; Valle C; Ferri A; Ngo ST; Loeffler JP
Cells; 2021 Jun; 10(6):. PubMed ID: 34207859
[TBL] [Abstract][Full Text] [Related]
12. Nutritional and metabolic support in patients with amyotrophic lateral sclerosis.
Muscaritoli M; Kushta I; Molfino A; Inghilleri M; Sabatelli M; Rossi Fanelli F
Nutrition; 2012 Oct; 28(10):959-66. PubMed ID: 22677356
[TBL] [Abstract][Full Text] [Related]
13. Energy metabolism in amyotrophic lateral sclerosis.
Dupuis L; Pradat PF; Ludolph AC; Loeffler JP
Lancet Neurol; 2011 Jan; 10(1):75-82. PubMed ID: 21035400
[TBL] [Abstract][Full Text] [Related]
14. CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
Tefera TW; Steyn FJ; Ngo ST; Borges K
Cell Biosci; 2021 Jan; 11(1):14. PubMed ID: 33431046
[TBL] [Abstract][Full Text] [Related]
15. Association between estimated total daily energy expenditure and stage of amyotrophic lateral sclerosis.
Lee J; Baek H; Kim SH; Park Y
Nutrition; 2017 Jan; 33():181-186. PubMed ID: 27544003
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of energy homeostasis in amyotrophic lateral sclerosis.
Guillot SJ; Bolborea M; Dupuis L
Curr Opin Neurol; 2021 Oct; 34(5):773-780. PubMed ID: 34343139
[TBL] [Abstract][Full Text] [Related]
17. Progressive Mitochondrial SOD1
Méndez-López I; Sancho-Bielsa FJ; Engel T; García AG; Padín JF
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360957
[TBL] [Abstract][Full Text] [Related]
18. What is "Hyper" in the ALS Hypermetabolism?
Ferri A; Coccurello R
Mediators Inflamm; 2017; 2017():7821672. PubMed ID: 29081604
[TBL] [Abstract][Full Text] [Related]
19. [Multidisciplinary care and therapeutic advances in amyotrophic lateral sclerosis].
Matamala JM; Moreno-Roco J; Acosta I; Hughes R; Lillo P; Casar JC; Earle N
Rev Med Chil; 2022 Dec; 150(12):1633-1646. PubMed ID: 37906785
[TBL] [Abstract][Full Text] [Related]
20. Hypermetabolism in ALS patients: an early and persistent phenomenon.
Bouteloup C; Desport JC; Clavelou P; Guy N; Derumeaux-Burel H; Ferrier A; Couratier P
J Neurol; 2009 Aug; 256(8):1236-42. PubMed ID: 19306035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
